Navigation Links
KV Begins Shipping Evamist(TM) to Wholesalers
Date:4/14/2008

alone substudy reported increased risks of stroke and deep vein thrombosis (DVT) in postmenopausal women (50 to 79 years of age) during 6.8 years and 7.1 years, respectively, of treatment with daily oral conjugated estrogens (CE 0.625 mg), relative to placebo. The estrogen plus progestin WHI substudy reported increased risk of myocardial infarction, stroke, invasive breast cancer, pulmonary emboli, and DVT in postmenopausal women (50 to 79 years of age) during 5.6 years of treatment with daily oral CE 0.625 mg combined with medroxyprogesterone acetate (MPA 2.5 mg), relative to placebo. The Women's Health Initiative Memory Study (WHIMS), a substudy of the WHI, reported increased risk of developing probable dementia in postmenopausal women 65 years of age or older during 5.2 years of treatment with daily CE 0.625 mg alone and during 4 years of treatment with daily CE 0.625 mg combined with MPA 2.5 mg, relative to placebo. It is unknown whether this finding applies to younger postmenopausal women. In the absence of comparable data, these risks should be assumed to be similar for other doses of CE and MPA and other combinations and dosage forms of estrogens and progestins. Because of these risks, estrogens with or without progestins should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman.

In a clinical trial with Evamist(TM), the most common side effects were headache, breast tenderness, nasopharyngitis, nipple pain, back pain, nausea, and arthralgia.

Evamist(TM) should not be used in women with undiagnosed abnormal genital bleeding; known, suspected, or history of breast cancer; known or suspected estrogen-dependent neoplasia; active deep vein thrombosis, pulmonary embolism, or history of these conditions; active or recent arterial thromboembolic disease; liver dysfunction or disease; or known or suspected pregnancy.

Full prescribing information for Evamist
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. When a Mind Begins to Disappear: A Young Familys Journey to the Dark Side
2. Annual National Public Health Week Begins Today
3. Viscorp, Inc. Announces Name Change to Tianyin Pharmaceutical Co Inc. and Begins Trading Under the Ticker OTC BB: TYNP
4. As Congress Begins Debate on Bush Budget, Front-Line Caregivers Urge Rejection of Medicare Cuts
5. XTend Medical (XMDC) Begins Remote Diabetic Telehealth Program
6. High blood pressure worsening in all states for women; begins to stagnate for men
7. Parental Alienation Awareness Organization Begins Preparations for Parental Alienation Awareness Day - April 25th
8. USA TODAY to Report Special Series "Turning 62: The Retirement Boom Begins"
9. Fitness Begins at Home
10. Work Begins on New Regional Hospital Medical Campus
11. Johnson City Medical Center Begins Offering Einstein Bros. Menu Items at Second On Campus Location
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... After more than five years of research ... GlobalSun (TM) — sunscreen specifically formulated for the unique skin of all people of ... the market just in time to help protect the skin of all people of ...
(Date:6/30/2015)... ... June 30, 2015 , ... The United Nations Foundation’s ... Club, announced the first-ever Why We Care Youth contest today. Why We Care Youth ... access to reproductive health and contraception has personally meant to them, and why U.S. ...
(Date:6/30/2015)... PA (PRWEB) , ... June 30, 2015 , ... ... Brain Tumor Center, has joined Allegheny Health Network (AHN) as Director ... interests involve the management of primary brain tumors, brain metastases, leptomeningeal disease and ...
(Date:6/30/2015)... Angeles, California (PRWEB) , ... June 30, 2015 ... ... applauds Congressmen Joe Kennedy III (D-MA) and Danny Davis (D-IL) for writing ... speed up its investigation into the nation’s largest behavioral healthcare system, Universal Health ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... D. Wagner, Chief Research and Strategy Officer at Predictive Analytics Reporting (PAR) Framework, ... National Science Foundation (NSF), will provide keynote addresses at the 2015 STEMtech conference ...
Breaking Medicine News(10 mins):Health News:GlobalSun – The First Sunscreen Developed for All People of Color – Hits The Market 2Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 2Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 4Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 2Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 3Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 2Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 3Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 4Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 5Health News:League for Innovation Announces Distinguished Keynote Presenters for STEMtech Conference 2Health News:League for Innovation Announces Distinguished Keynote Presenters for STEMtech Conference 3
... the ensuing AIDS epidemic, a frightening group of people ... about the virus. Seth Kalichman, editor of the journal ... new book Denying AIDS, published by Springer. Denying AIDS ... the scientific and sociopolitical forces involved in AIDS denial. ...
... live close to some type of emergency room, as many ... away from the type of hospital that,s most prepared to ... a new University of Pennsylvania School of Medicine study published ... little is known about which U.S. hospitals are best equipped ...
... Church FALLS CHURCH, Va., March 17 U.S. ... and public health leaders from Virginia will hold a press ... quick passage of federal legislation that would grant the U.S. ... The House Energy and Commerce Committee passed the bill earlier ...
... 17 Herley Industries, Inc. (Nasdaq: HRLY ) ... Annual Stockholders, Meeting today at The Eden Resort Inn in ... coming. At last year,s annual shareholders meeting, I said we ... the reasonably near term. We now have a new President ...
... 17 Urban Health Plan, a network of federally ... from the Economic Stimulus Package (the American Recovery and ... in Corona, Queens. Paloma Izquierdo-Hernandez, President and CEO of ... Economic Stimulus Package funding from the federal government. The ...
... healthcare payment and clearinghouse solutions via a proprietary ... March 17 InstaMed, the industry leading healthcare ... Bala Cynwyd Pennsylvania-based venture capital firm, has joined ... growth equity financing. Ashby Point Capital of Arnold ...
Cached Medicine News:Health News:The human tragedy of denying AIDS 2Health News:1 in 4 Americans lacks timely access to optimal care during time-sensitive medical emergencies 2Health News:1 in 4 Americans lacks timely access to optimal care during time-sensitive medical emergencies 3Health News:U.S. Rep. Connolly, Inova Hospital Physicians, Public Health Groups Call for Congressional Action to Protect Kids From Tobacco 2Health News:Herley Chairman Addresses Shareholders at Annual Meeting of Shareholders March 17, 2009 2Health News:Herley Chairman Addresses Shareholders at Annual Meeting of Shareholders March 17, 2009 3Health News:Herley Chairman Addresses Shareholders at Annual Meeting of Shareholders March 17, 2009 4Health News:Urban Health Plan Receives $1.3M from Economic Stimulus Package to Increase Health Care Access in Corona, Queens 2Health News:InstaMed Announces Osage Partners and Ashby Point Capital Have Joined Existing Investors in $6 Million Growth Equity Financing 2Health News:InstaMed Announces Osage Partners and Ashby Point Capital Have Joined Existing Investors in $6 Million Growth Equity Financing 3
(Date:6/30/2015)... KOPENHAGEN, Dänemark, 30. Juni 2015 ... der klinischen und kommerziellen Produktion von monoklonalen ... bekannt, dass das Unternehmen im Rahmen seiner ... nordamerikanischen Produktionsanlage in Bothell, Washington ... Bioreactor 6Pack™ komplettiert hat. Die Konfiguration Bioreactor ...
(Date:6/30/2015)... June 30, 2015  Marken, the leading clinical trial ... sciences industry, has been granted permission by the government ... clinical drug product in Korea.  This precedent-setting shipment has ... to continue receiving their clinical trial drugs during ... The emergency was caused by recent partial closures ...
(Date:6/30/2015)... PharmaVentures is pleased to announce ... Oy (CMT) on its divestment of certain assets to ... world leading capabilities in cellular imaging and analysis. ... of successful global deals in the life science research ... Walton , CEO, PharmaVentures, commented: "PharmaVentures is delighted to ...
Breaking Medicine Technology:CMC Biologics baut GMP-Produktionskapazität in den USA aus 2CMC Biologics baut GMP-Produktionskapazität in den USA aus 3Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3PharmaVentures Completes M&A Deal for Technology in the Stem Cell & Regenerative Medicine Sector 2
... Perrigo Company today announced that it will attend the ... Asthma & Immunology Conference (ACAAI) Nov. 3-8 at the ... Boston. The ACAAI is a professional ... the medical subspecialty of allergy and immunology.  It is ...
... The oncology market continues to be a rapid ... aspects of successfully launching a new oncology product is ... Strategic Marketing function. The regulatory environment, ... marketplace present significant challenges for Global Strategic Marketing (GSM) ...
Cached Medicine Technology:Perrigo Company to Attend the 2011 Annual Meeting of the American College of Allergy, Asthma & Immunology 2Perrigo Company to Attend the 2011 Annual Meeting of the American College of Allergy, Asthma & Immunology 3Global Strategic Marketing Key to Success in Oncology Launches in the Pharmaceutical Sector 2
Replacement block for Tanne corneal punch....
... An Ultra-Fine point marker for the surgeons exacting ... to broad line marking system and a point ... their requirements. A Ruler, an optional convenience that ... or smear upon contact with liquids. The ink ...
Periosteal elevator, freer....
... The Surgifoam* absorbable gelatin sponge, U.S.P. ... gelatin absorbable sponge intended for hemostatic ... surface. The sponge is off-white and ... speed to hemostasis, highly favorable surgeon ...
Medicine Products: